Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update
Over the last two decades, haematopoietic stem cell transplantation (HSCT) has been explored as a potential therapeutic strategy for autoimmune diseases refractory to conventional treatments, including neurological disorders. Although both autologous (AHSCT) and allogeneic HSCT (allo-HSCT) were inve...
Main Authors: | Alice Mariottini, Giovanni Bulgarini, Sara Cornacchini, Valentina Damato, Riccardo Saccardi, Luca Massacesi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/10/2/176 |
Similar Items
-
Experience of using Rituximab in neurological practice (literature review and own observation)
by: Ya. B. Kushnir, et al.
Published: (2021-11-01) -
Monoclonal Antibodies as Neurological Therapeutics
by: Panagiotis Gklinos, et al.
Published: (2021-01-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice
by: Lukas Theissen, et al.
Published: (2024-03-01) -
Steroid myopathy in patients with myasthenia gravis: a literature review
by: S. A. Zaytsevskaya, et al.
Published: (2024-09-01)